Published: 7 February 2022
Author(s): Hiroshi Ito
Issue: April 2022
Section: Letter to the Editor

According to Humphrey and colleagues, one-third of patients with intravenous insulin-dextrose (IDex) for hyperkalemia needed repeated treatments with IDex [1]. Besides, approximately 20% of patients who underwent IDex developed hypoglycemia with a serum glucose level

Newsletters

Stay informed on our latest news!